Tag: Stent
Abbott introduces its most advanced drug eluting stent ‘XIENCE Skypoint’ in...
XIENCE Skypoint has the broadest size range and is the only one indicated for vessels up to 5.25 mm
Cordis unveils positive results for two SELUTION SLR DEB trials
SELUTION DeNovo Trial – the largest randomized Drug-Eluting Balloon trial - demonstrates a SELUTION SLR™ DEB strategy is non-inferior to a Drug-Eluting Stent treatment strategy in de novo lesions
India coronary stent market set for 4% CAGR growth during 2024-2033,...
India’s coronary drug eluting stent market accounts for around 32% of the Asia-Pacific market in 2024
Abbott introduces XIENCE Sierra stent in India
This latest addition to Abbott's XIENCE™ family offers a breakthrough solution for individuals battling with blocked coronary arteries, offering unmatched safety and efficacy even in the most complex cases
Terumo India advances treatment options for heart disease with launch of...
Ultimaster Nagomi™, by Terumo India, is one such new generation Drug-Eluting Stent that can facilitate smooth navigation to complex arteries and adapt to any vessel size with ease
USFDA issues world’s first IDE approval to India’s Concept Medical for...
U.S. Hearts will be treated by made-in-India, Magictouch from Concept Medical, says Dr Manish Doshi
India’s first indigenous flow diverter stent device to be in market...
The cost of the Chitra Flow Diverter stent for correcting ballooning of brain arteries & device for the healing of the heart hole is expected to be priced significantly lower than the currently imported ones......................
Meril Life Sciences receives CE marking for 100 micron bioresorbable scaffold
MeRes100, a next-generation thin-strut bioresorbable scaffold (BRS), is indigenously designed, developed and manufactured by Meril Life Sciences in India.................
Fixing medicine prices saved ₹11,462 crore for patients: Govt
As per the union minister, Mr Mansukh L. Mandaviya, the ceiling prices of 856 medicines fixed by the National Pharmaceutical Pricing Authority (NPPA), resulted in a saving of Rs 11,462 crore for patients. He ruled out any shortage of coronary stents due to price fixation...…………...
Made in India Supraflex stent clinically at par with Abbott’s Xience,...
The findings of the TALENT trial presented at the Transcatheter Cardiovascular Therapeutics 2018 (TCT) conference in San Diego, USA establishes India's largest stent manufacturer SMT’s Supraflex stent clinically at par with Abbott’s Xience family, with a numerically better outcome...…………..